M. Pham

The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance.

S. Westin, E. Hinchcliff, M. Ávila, 2021, Cancer journal.

Targeting the PI3K Pathway in Gynecologic Malignancies

S. Westin, M. Ávila, M. Pham, 2022, Current Oncology Reports.

Targeting the replication stress response through synthetic lethal strategies in cancer medicine.

T. Yap, D. Tan, N. Ngoi, 2021, Trends in cancer.

Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises.

G. Peng, T. Yap, N. Ngoi, 2021, Trends in cancer.